The largest database of trusted experimental protocols

Genemapper v4

Manufactured by Thermo Fisher Scientific
Sourced in United States, United Kingdom, Germany

GeneMapper v4.0 is a software application developed by Thermo Fisher Scientific for DNA fragment analysis. It provides a platform for the automated detection and sizing of DNA fragments generated from various genetic analysis techniques, such as PCR amplification and capillary electrophoresis. The software enables the analysis and interpretation of DNA sequence data, facilitating applications in genetic research, forensics, and diagnostic testing.

Automatically generated - may contain errors

280 protocols using genemapper v4

1

Rapid CE-ribotyping of C. difficile

Check if the same lab product or an alternative is used in the 5 most similar protocols
Amplification of 16S-23S intergenic spacer regions was performed using the ECDIS-net protocol, using primers described by Stubbs et al. (Stubbs et al., 1999) . Capillary electrophoresis was performed using an ABI 3130 Genetic Analyser (Applied Biosystems), a 36 cm array length, default fragment analysis, POP7 polymer and LIZ1200 (Applied Biosystems) as a size standard. The ribotypes were determined using the freely available WEBRIBO database (https://webribo.ages.at/) (Indra et al., 2008) after Gene Mapper® v4.0 (Applied Biosystems) software processing. Subsequently, the CEribotyping profiles obtained were also compared with the Leeds-Leiden C. difficile reference strain set of CE-ribotyping profiles (n=70) generated using Gene Mapper® v4.0 software (Applied Biosystems) from *.fsa files used at the first stage of the CE-ribotyping validation study (Fawley et al., 2015) .
+ Open protocol
+ Expand
2

miRNA Expression Quantification Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
The target peak was identified based on electrophoretic mobility obtained by GeneMapper v4.1 (Applied Biosystems), with which we calibrated the mobility based on the size standards mixed in every electrophoresis run. All the target peaks have highly reproducible mobility after the calibration (Supplementary Table S3). miRNA expression levels were determined by dividing the area of each target peak by the total peak area of reference probes (mir-159a and snoRNA U18). mir-159a was used as spike-in control, and snoRNA U18 was used as an endogenous control. The individual peak area for each small RNA were obtained by Gene Mapper v4.1 software (Applied Biosystems). Karp et al. also used snoRNA U18 as an internal control for qRT-PCR assays, and their findings were comparable with our assay results8 (link). All miRNA assays were performed with at least three replicates.
+ Open protocol
+ Expand
3

Genotypic Sex Determination Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
As phenotypic sex cannot be assessed prior to stage G43, we genotyped all sampled individuals to assess their genotypic sex using three markers with Y-diagnostic alleles (namely Dmrt1-1, Dmrt1-2, Dmrt1-5) (primer sequences from [52 (link)]; Supplementary Table S1). After an overnight treatment at 56 °C with tissue lysis buffer ATL and 20% proteinase K (Qiagen), PCR reactions were performed in a total volume of 10 µL, including 3 µL of extracted DNA, 2.22 µL of Milli-Q water, 3 µL of Qiagen Multiplex Master Mix, 0.14 to 0.3 µL of labeled forward primer, and 0.14 to 0.3 µL of unlabeled reverse primer (in total 1.78 µL of primer mix). PCRs were conducted on Perkin Elmer 2700 machines using the following thermal profile: 15 min of Hot Start Taq polymerase activation at 95 °C, followed by 35 cycles including denaturation at 94 °C for 30 s, annealing at 55 °C for 1.5 min, and elongation at 72 °C for 1 min, ending the PCR with a final elongation of 30 min at 60 °C. PCR products were then analyzed on an automated ABI Prism 3100 sequencer (Applied Biosystems, Foster City, CA, USA) and alleles were scored using GENEMAPPER v. 4.0 (Applied Biosystems).
+ Open protocol
+ Expand
4

Genotyping SNPs in Muscle Tissue

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total genomic DNA was extracted from the longissimus muscle using the LaboPass TM Tissue Mini kit (Cosmo Genetech, Seoul, Korea). Two polymorphic SNPs of SREBPs and six polymorphic SNPs of the FABP4 gene in GenBank were genotyped according to Oh et al [27 (link)]. Primers for amplifications and extensions were designed for the single-base extension (Ed- this acronym is not used anywhere in the paper) for genotyping polymorphic sites [33] using forward, reverse, and extension primer sequences [27 (link)]. Reactions of the primer extension were performed using the SNaPshotddNTP Primer Extension Kit (Applied Biosystems, Foster City, CA, USA). One unit of shrimp alkaline phosphatase was added to the reaction mixture, which was then incubated for 1 h at 37°C, followed by 15 min at 72°C for enzyme inactivation, to clean the primer extension reaction. DNA samples containing extension products and the Gene-scan 120 LIZ size standard solution were added to Hi-Di formamide (Applied Biosystems, USA) in accordance with the manufacturer’s recommendations. The mixture was incubated for 5 min at 95°C, followed by 5 min on ice, after which electrophoresis was conducted using the ABI PRISM 3130XL GeneticAnalyzer. The analysis was made using GeneMapper v4.0 (Applied Biosystems, USA).
+ Open protocol
+ Expand
5

Repeat-Primed PCR for Repeat Expansion

Check if the same lab product or an alternative is used in the 5 most similar protocols
Repeat-primed PCR was performed on all samples lacking PCR-amplifiable products on standard flanking PCR (n=89). The repeat-primed PCR assay was performed for each of three pentanucleotide repeat units [AAAAG/AAAGG/AAGGG] using primers, reagents, and methods, as described in Cortese et al.(Cortese et al, 2019 (link)). Repeat-primed PCR products were separated on an ABI3730xl DNA Analyzer (Applied Biosystems®, Foster City, CA). The results were visualized using GeneMapper® v.4.0 (Applied Biosystems®). Repeat-primed PCR determines if a sample carries a repeat expansion. However, this method does not allow for accurate measurement of the repeat size of large expansions due to signal dropoff after approximately 1,000bp (equivalent to 200 repeats for a pentanucleotide motif).
+ Open protocol
+ Expand
6

Microsatellite Genotyping of M. phoenicea

Check if the same lab product or an alternative is used in the 5 most similar protocols
We used 26 microsatellite loci specific to the morpho‐species M. phoenicea (Postaire et al., 2015), using the same PCR conditions. PCR products were genotyped using an ABI 3730 genetic analyzer (Applied Biosystems), and allelic sizes were determined on GeneMapper v.4.0 (Applied Biosystems) using an internal size standard (GeneScan LIZ‐500; Applied Biosystems). Considering the whole dataset, over the 26 available loci for M. phoenicea sp., 15 amplified correctly M. phoenicea α individuals, that is, presented less than 10% of missing data, and were considered for all analyses. For each sampling site, identical multilocus genotypes (MLGs) were identified with GenClone v.2.0 and clonal richness R [(NMLG − 1)/(N − 1)] was assessed (Arnaud‐Haond & Belkhir, 2007; Table 1).
+ Open protocol
+ Expand
7

High-Throughput Community Analysis of AM Fungi

Check if the same lab product or an alternative is used in the 5 most similar protocols
Each of the four rings for each atmospheric treatment at the SoyFACE experiment can be viewed as a true replicate. In order to utilize this level of replication, a higher throughput method for community analysis was required. The AM fungal communities of three of the plant root systems from each of the 16 treatment rings from 2006 and 2008 were therefore characterized using TRFLPs. Dual-labelled partial SSU rRNA gene sequences of AM fungi were produced as described previously for clone library production, but with the AM1 and NS31 primers labelled with FAM and HEX dyes, respectively (Eurofins MWG Operon, Ebersberg, Germany) and with an annealing temperature of 63°C. Labelled PCR products of c. 550 bp were cleaned by gel extraction using a 1.2% agarose gel and QIAquick Gel Extraction Kit (Qiagen) following the manufacturer's instructions.
Eight microlitres of each cleaned PCR product were separately digested using five units of HinfI and AluI (Promega) in a reaction volume of 15 μl containing the manufacturer's buffer and 2 μg BSA for 15 h, and restriction products were cleaned using a QIAquick PCR Purification Kit (Qiagen). The sizes and quantities of FAM-labelled AluI digests and HEX-labelled HinfI digests were determined against the GS600 LIZ size standard employing an ABI 3130 genetic analyser (and its supplied software: GeneMapper v4.0; Applied Biosystems).
+ Open protocol
+ Expand
8

Genetic Analysis of Otosclerosis Families

Check if the same lab product or an alternative is used in the 5 most similar protocols
Genomic DNA was isolated from peripheral leukocytes according to a standard salting out procedure (Miller et al. 1988 (link)). Microsatellite markers were fluorescently labeled and amplified by PCR, run on ABI 3130xl or 3730 (Applied Biosystems) and analyzed with Gene Mapper v4.0. Pedigrees were drawn with Progeny (Progeny Genetics LLC) and haplotypes phased manually with the least number of recombination events. To test for linkage in the NL family, five affected members (PIDs II-2, II-3, II-6, II-9, III-2; otosclerosis confirmed by surgery) and two of unknown clinical status (PIDs III-5, III-6) (Fig. 2a) were genotyped for markers spanning each OTSC disease interval and bracketing three otosclerosis susceptibility genes (Supplementary Table 1). As well, a total of 17 relatives were genotyped with nine extra markers (D16S518, D16S3049, D16S3098, D16S422, D16S2625, D16S520, D16S413, D16S3023, D16S3026) mapping qter of the OTSC4 disease interval. Two-point parametric linkage analyses (MLINK ver 5.1) were run for three markers per locus (assuming autosomal dominant inheritance, 99% penetrance and a gene frequency of 0.00). LOD scores were calculated at recombination fractions 0.000 to 0.5000. The proband was also sequenced for rare otosclerosis-associated variants in SERPINF1 (Ziff et al. 2016 (link)).
+ Open protocol
+ Expand
9

Microsatellite Analysis of Aedes albopictus

Check if the same lab product or an alternative is used in the 5 most similar protocols
DNA was extracted from individual mosquitoes using a cetyltrimethylammonium bromide (CTAB) protocol [39 ]. A total of 564 individuals were genotyped (24–30 individuals per site). In each site, half of the analyzed individuals were males and the other half females. A set of 16 microsatellite loci previously developed for Ae. albopictus was used [32 (link), 34 (link)] (Additional file 2: Table S2). Microsatellite locus primers were pooled in three PCR-mixes based on non-overlapping size ranges and amplified by multiplex PCRs using fluorescent primers (Additional file 2: Table S2). All PCR reactions (10 µl) contained 0.5 U of Taq DNA polymerase, 6 µM of dNTPs, 37.5 µM of MgCl2, 1.2–7 µM of each primer (Additional file 2: Table S2) and 10 ng of mosquito DNA. The following program was used to amplify all 16 loci: 10 min at 95 °C followed by 35 cycles at 95 °C for 30 s, 57 °C for 30 s and 72 °C for 1 min and a final elongation step of 72 °C for 10 min. PCR products were run on a 3730XL DNA Genetic Analyzer (Applied Biosystems, California, USA) with a GeneScan 500LIZ size standard. Microsatellite alleles were read using the software GeneMapper v. 4.0 (Applied Biosystems).
+ Open protocol
+ Expand
10

Isolation and Characterization of Sarcoma Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
With approval of the Institutional Review Board (IRB) of The University of Texas MD Anderson Cancer Center and with patient’s written informed consent, isolation of tumor cells was performed as described previously.35 (link) Cells were cultured in DMEM supplemented with 10% fetal bovine serum (FBS) (Gemini bio-products, West Sacramento, CA) and 1% penicillin-streptomycin (100U/ml), and placed in a humidified 5% CO2 incubator at 37°C. The previously established human MLS cell lines 402-91 and 1765-92 were cultured in RPMI1640 (Thermo Fisher Scientific, Waltham, MA) supplemented with FBS and antibiotics. The population doubling time was calculated during the exponential growth phase using the algorithm provided by Doubling Time software (http://www.doubling-time.com). All cell lines were tested on a regular basis for mycoplasma infection. Short Tandem Repeat (STR) DNA fingerprinting was performed on the cell lines, the metastatic tumor tissue from which the DL-221 cell line was derived and from xenografted tissue (AmpFLSTR Identifiler PCR Amplification kit; Applied Biosystems, Foster City, CA). The data was analyzed with GeneMapper (v4.0, Applied Biosystems).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!